As COVID-19 cases rise in India, the demand for Remdesivir is increasing. This has led to a huge gap between demand and supply, leaving room for black marketing. The drug regulator of India has taken measures to clamp it down.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3